Merus NV (MRUS)
51.74
+0.52
(+1.01%)
USD |
NASDAQ |
Nov 05, 16:00
51.74
0.00 (0.00%)
After-Hours: 18:43
Merus Shareholders Equity (Quarterly): 703.26M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 703.26M |
| June 30, 2024 | 746.77M |
| March 31, 2024 | 349.45M |
| December 31, 2023 | 356.34M |
| September 30, 2023 | 393.39M |
| June 30, 2023 | 257.40M |
| March 31, 2023 | 217.52M |
| December 31, 2022 | 247.06M |
| September 30, 2022 | 298.78M |
| June 30, 2022 | 326.61M |
| March 31, 2022 | 297.47M |
| December 31, 2021 | 316.20M |
| September 30, 2021 | 205.77M |
| June 30, 2021 | 219.09M |
| March 31, 2021 | 236.54M |
| December 31, 2020 | 102.26M |
| September 30, 2020 | 84.50M |
| June 30, 2020 | 100.30M |
| March 31, 2020 | 114.59M |
| December 31, 2019 | 131.30M |
| Date | Value |
|---|---|
| September 30, 2019 | 77.00M |
| June 30, 2019 | 87.29M |
| March 31, 2019 | 97.66M |
| December 31, 2018 | 105.86M |
| September 30, 2018 | 98.68M |
| June 30, 2018 | 107.38M |
| March 31, 2018 | 117.58M |
| December 31, 2017 | 67.89M |
| September 30, 2017 | 70.15M |
| June 30, 2017 | 83.23M |
| March 31, 2017 | 97.55M |
| December 31, 2016 | 35.79M |
| September 30, 2016 | 71.51M |
| June 30, 2016 | 76.04M |
| March 31, 2016 | 26.29M |
| December 31, 2015 | 30.94M |
| September 30, 2015 | 38.41M |
| June 30, 2015 | -9.417M |
| December 31, 2014 | -4.328M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
84.50M
Minimum
Sep 2020
746.77M
Maximum
Jun 2024
285.23M
Average
252.23M
Median
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 97.11M |
| ProQR Therapeutics NV | 35.22M |
| argenx SE | -- |
| Pharming Group | 225.79M |
| Pharvaris NV | 356.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 844.68M |
| Total Liabilities (Quarterly) | 141.42M |
| Current Ratio | 8.320 |